5AM Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 22

Professionals
  • Investments
  • 209

  • Portfolio
  • 42

  • Exits
  • 74

Exits

5AM Ventures General Information

Description

Founded in 2002, 5AM Ventures is a venture capital firm based in San Francisco, California. The firm seeks to invest in advanced life science technologies, biopharmaceutical, drug delivery technology and research instrument sectors.

Contact Information

Year Founded
2002
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
  • 501 Second Street
  • Suite 350
  • San Francisco, CA 94107
  • United States
+1 (415) 000-0000

5AM Ventures Investments (209)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Magnetic Insight 23-Jun-2022 Later Stage VC 0000 Diagnostic Equipment Generating Revenue 00000 0000000 00.0
0000 13-May-2022 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue 000000 000000
00000000 000000000 19-Apr-2022 00000 00000 00000 Biotechnology Pre-Clinical Trials
0000000 0000000000 19-Jan-2022 00000 00000 000.00 Drug Discovery Startup 000000 000000
0000 000000000000 03-Dec-2021 0000 00000 Other Healthcare Technology Systems Generating Revenue/Not Profitable 000000 000000
00000000 05-Nov-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 0000 00000000000 00.0
00000000000 000000 18-Oct-2021 00000 00000 0000 Drug Discovery Startup 00000 0000000 00.0
000000000 00000000 29-Sep-2021 00000 00000 0000 Drug Discovery Generating Revenue
CinCor Pharma 22-Sep-2021 Early Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable 00000 0000000 00.0
RareCyte 09-Sep-2021 Later Stage VC 0000 Diagnostic Equipment Generating Revenue 000000 000000
You’re viewing 10 of 209 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

5AM Ventures Exits (74)

Company Name Exit Date Exit Type Exit Size
CinCor Pharma 07-Jan-2022 IPO 00000
0000 000000000000 03-Dec-2021 0000000 000000 00000
0000000 0000000000 02-Nov-2021 000 00000
00000 00000000000 10-Sep-2021 000000 0000000000 0000
00000000 29-Jul-2021 000 000.00
000000000 00000000 01-Jun-2021 000000000000000000
00000 00000000000 22-Apr-2021 000 0000
000 000000000 05-Feb-2021 000 00000
Chrono Therapeutics 01-Feb-2021 Out of Business
5:01 Acquisition 14-Oct-2020 IPO 0000
You’re viewing 10 of 74 exits. Get the full list »

5AM Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore 5AM Ventures‘s full profile, request access.

Request a free trial

5AM Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

5AM Ventures Team (71)

Name Title Deals Funds Boards Office
Rebecca Lucia Chief Financial Officer, Chief Operating Officer and Partner San Francisco, CA
Andrew Schwab Co-Founder & Managing Partner 00 0 00 San Francisco, CA
John Diekman Ph.D Co-Founding Partner 00 0 0 San Francisco, CA
Scott Rocklage Ph.D Co-Founding Partner 00 0 0 Boston, MA
James Young Ph.D Venture Partner 0 0 0 San Francisco, CA
You’re viewing 5 of 71 team members. Get the full list »

5AM Ventures Co-Investors (191)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 9 0 0 Series chart Industry bar
Roche Venture Fund 0 00 Series chart Industry bar
OrbiMed 0 00 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 Series chart Industry bar
You’re viewing 5 of 191 co-investors. Get the full list »